Skip to main content

Advertisement

SpringerLink
Log in

Central sleep apnea and hypoventilation syndrome

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Central sleep apnea hypopnea syndrome (CSAHS) and sleep hypoventilation syndrome (SHVS) are two distinct clinical syndromes with clearly defined diagnostic criteria. It is important to distinguish between normo/hypocapnic and hypercapnic CSAHS prior to treatment. Nasal continuous positive airway pressure is currently considered the primary treatment of choice for normo/hypocapnic CSAHS. The initial management of hypercapnic CSAHS and SHVS should include identification of any treatable causes and discontinuation of any sedative medications. Medroxyprogesterone may be effective in the long term management of these patients. If pharmacologic therapy fails, assisted ventilation should be considered. Assisted ventilation during the night is usually sufficient to improve hypercapnia and hypoxemia both at night and during the day. Assisted ventilation is usually best administered through a tight fitting nasal mask.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. American Academy of Sleep Medicine Task Force: Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999, 22:667–689. Consensus report on the key features of three syndromes associated with sleep disordered breathing. It also recommends methods of measuring the key features of these syndromes.

    Google Scholar 

  2. Bradley TD, Phillipson EA: Central sleep apnea. Clin Chest Med 1992, 13:493–505.

    PubMed  CAS  Google Scholar 

  3. Dowell AR, Buckley CE, Cohen R, et al.: Cheyne-Stokes respiration: a review of clinical manifestations and critique of physiological mechanisms. Arch Intern Med 1971, 127:712–26. Class III

    Article  PubMed  CAS  Google Scholar 

  4. Issa FG, Sullivan CE: Reversal of central sleep apnea using nasal CPAP. Chest 1986, 90:165–171.

    PubMed  CAS  Google Scholar 

  5. Naughton MT, Liu PP, Benard DC, et al.: Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 1995, 151:92–97.

    PubMed  CAS  Google Scholar 

  6. Sin DD, Logan AG, Fitzgerald FS, et al.: Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000, 102:61–66. Randomized controlled trial of nasal CPAP in 66 patients with congestive heart failure. Nasal CPAP treatment was associated with a 8% increase in left ventricular ejection fraction and 81% relative risk reduction in mortality-cardiac transplantation rate in patients with Cheyne-Stroke respiration.

    PubMed  CAS  Google Scholar 

  7. Davies RJO, Harrington KJ, Ormerod OJM, et al.: Nasal continuous positive airway pressure in chronic heart failure with sleep disordered breathing. Am Rev Respir Dis 1993, 147:630–634.

    PubMed  CAS  Google Scholar 

  8. Hanly PJ, Millar TW, Steljes DG, et al.: The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 1989, 111:777–782.

    PubMed  CAS  Google Scholar 

  9. Franklin KA, Eriksson P, Sahlin C, Lundgren R: Reversal of central sleep apnea with oxygen. Chest 1997, 111:163–169.

    PubMed  CAS  Google Scholar 

  10. Badr MS, Grossman JE, Weber SA: Treatment of refractory sleep apnea with supplemental carbon dioxide. Am J Respir Crit Care Med 1994, 150:561–564.

    PubMed  CAS  Google Scholar 

  11. Bonnet MH, Dexter JR, Arand DL: The effect of triazolam on arousal and respiration in central sleep apnea patients. Sleep 1990, 13:31–41.

    PubMed  CAS  Google Scholar 

  12. Lyons HA, Huang CT: Therapeutic use of progesterone in alveolar hypoventilation associated with obesity. Am J Med 1968, 44:881–888.

    Article  PubMed  CAS  Google Scholar 

  13. Sutton FD, Zwillich CW, Creagh CE, et al.: Progesterone for outpatient treatment of Pickwickian syndrome. Ann Intern Med 1975, 83:476–479.

    PubMed  Google Scholar 

  14. Sutton JR, Houston CS, Mansell AL, et al.: Effect of acetazolamide on hypoxemia during sleep at high altitude. N Engl J Med 1979, 310:1329–1331.

    Article  Google Scholar 

  15. Sharp JT, Druz WS, D’Souza V, Diamond E: Effect of metabolic acidosis upon sleep apnea. Chest 1985, 87:619–624.

    PubMed  CAS  Google Scholar 

  16. JavaheriS, Parker TJ, Wexler L, et al.: Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996, 335:562–567. Randomized, double-blind crossover study of 15 men with stable heart failure and periodic breathing.

    Article  PubMed  CAS  Google Scholar 

  17. Ellis ER, McCauley VB, Mellis C, Sullivan CE: Treatment of alveolar hypoventilation in a six-year-old girl with intermittent positive pressure ventilation through a nose mask. Am Rev Respir Dis 1987, 136:188–191.

    PubMed  CAS  Google Scholar 

  18. Guilleminault C, Stoohs R, Schneider H, et al.: Central alveolar hypoventilation and sleep: Treatment by intermittent positive pressure ventilation through nasal mask in adult. Chest 1989, 96:1210–1212.

    PubMed  CAS  Google Scholar 

  19. Thommi G, Nugent K, Bell GM, Liu J: Termination of central sleep apnea episodes by upper airway stimulation using intermittent positive pressure ventilation. Chest 1991, 99:1527–1529.

    PubMed  CAS  Google Scholar 

  20. Kerby GR, Mayer LS, Pingleton SK: Nocturnal positive pressure ventilation via nasal mask. Am Rev Respir Dis 1988, 135:738–740.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Respiratory Division, Department of Medicine, University of British Columbia and Vancouver Hospital, 2775 Heather Street, V5Z 3J5, Vancouver, British Columbia, Canada

    Wee See Yap MD & John A. Fleetham MD, FRCPC

Authors
  1. Wee See Yap MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John A. Fleetham MD, FRCPC
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yap, W.S., Fleetham, J.A. Central sleep apnea and hypoventilation syndrome. Curr Treat Options Neurol 3, 51–55 (2001). https://doi.org/10.1007/s11940-001-0023-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-001-0023-8

Keywords

Search

Navigation